Surgical/Critical Care

ID 50985028 © Designer491 | Dreamstime.com
pancreatic_cancer
The findings show that patients with metastatic pancreatic cancer who received the drug lived a median of 13.2 months, compared to 6.7 for standard chemotherapy.
Oct. 30, 2026